Onex Canada Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Onex Canada Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$24K	–	182
2021 Q1	$24K	Hold	10,000	–	–	﹤0.01%	205
2020 Q4	$18K	Hold	10,000	–	–	﹤0.01%	133
2020 Q3	$9K	Hold	10,000	–	–	﹤0.01%	135
2020 Q2	$9K	Hold	10,000	–	–	﹤0.01%	131
2020 Q1	$8K	Hold	10,000	–	–	﹤0.01%	134
2019 Q4	$9K	Hold	10,000	–	–	﹤0.01%	130
2019 Q3	$10K	Hold	10,000	–	–	﹤0.01%	122
2019 Q2	$11K	Hold	10,000	–	–	﹤0.01%	122
2019 Q1	$13K	Hold	10,000	–	–	﹤0.01%	116
2018 Q4	$9K	Sell	10,000 -1,430	-13%	-$2.19K	﹤0.01%	99
2018 Q3	$23K	Hold	11,430	–	–	﹤0.01%	107
2018 Q2	$21K	Sell	11,430 -2,057	-15%	-$4.14K	﹤0.01%	102
2018 Q1	$32K	Hold	13,487	–	–	﹤0.01%	86
2017 Q4	$25K	Hold	13,487	–	–	﹤0.01%	94
2017 Q3	$34K	Hold	13,487	–	–	﹤0.01%	66
2017 Q2	$37K	Hold	13,487	–	–	﹤0.01%	93
2017 Q1	$41K	Hold	13,487	–	–	﹤0.01%	81
2016 Q4	$43K	Hold	13,487	–	–	﹤0.01%	87
2016 Q3	$45K	Hold	13,487	–	–	﹤0.01%	87
2016 Q2	$31K	Hold	13,487	–	–	﹤0.01%	88
2016 Q1	$34K	Sell	13,487 -1,133	-8%	-$2.53K	﹤0.01%	95
2015 Q4	$48K	Buy	+14,620	New	+$43.7K	﹤0.01%	85

Other funds holding LCTX

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Onex Canada Asset Management's LCTX Position: Q2 2021 in Review

Onex Canada Asset Management sold out of Lineage Cell Therapeutics (LCTX) in Q2 2021, closing a stake of 10,000 shares — an estimated $24K sold.

Onex Canada Asset Management first reported a position in LCTX in Q4 2015 and held it in 22 quarters. The position peaked at $48K in Q4 2015. 115 funds tracked by Wall St. Rank hold LCTX as of Q2 2021.

Onex Canada Asset Management reported no remaining Lineage Cell Therapeutics position as of Q2 2021 after selling out during the quarter.
Onex Canada Asset Management sold 10,000 Lineage Cell Therapeutics shares in Q2 2021, an estimated $24K.
Onex Canada Asset Management first reported a position in Lineage Cell Therapeutics in Q4 2015 and held it in 22 quarters.
Onex Canada Asset Management's Lineage Cell Therapeutics position peaked at $48K in Q4 2015.
115 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q2 2021.

Based on Onex Canada Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.